We have identified 24 molecular markers, based on circulating nucleic acids (CNA) originating from the human genome, which in combination can be used in a quantitative real-time PCR (qPCR) assay to identify the presence of human sepsis, starting two to three days before the first clinical signs develop and including patients who meet the SEPSIS-3 criteria. The accuracy was more than 87% inside of the same patient cohort for which the markers were developed and up to 81% in blind studies of patient cohorts which were not included in the marker development. As our markers are host-based, they can be used to capture bacterial as well as fungal sepsis, unlike the current PCR-based tests, which require species-specific primer sets for each organism causing human sepsis. Our assay directly uses an aliquot of cell-free blood as the substrate for the PCR reaction, thus allowing to obtain the diagnostic results in three to four hours after the collection of the blood samples.
ASJC Scopus subject areas
- !!Biochemistry, Genetics and Molecular Biology (miscellaneous)
Fields of Expertise
- Human- & Biotechnology
- Information, Communication & Computing
Treatment code (Nähere Zuordnung)